(Q42093118)

16 October 2017

Should physicians give tPA to patients with acute ischemic stroke? Against: and just what is the emperor of stroke wearing? (English)

1 reference

16 October 2017

Hoffman JR

1

1 reference

PMC publication ID

1071041

16 October 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Western Journal of Medicine

16 October 2017

1 reference

16 October 2017

173

1 reference

16 October 2017

3

1 reference

16 October 2017

149-150

1 reference

Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: simulation model

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Thrombolytic therapy with streptokinase in acute ischemic stroke

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Conditions that mimic stroke in the emergency department. Implications for acute stroke trials

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Tissue plasminogen activator for acute ischemic stroke

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators

16 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1071041

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

17 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10986160

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Low-Molecular-Weight Heparin for the Treatment of Acute Ischemic Stroke

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/10986160

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/EWJM.173.3.149

1 reference

16 October 2017

1 reference

PMC publication ID

1071041

16 October 2017

PubMed publication ID

10986160

1 reference

PMC publication ID

1071041